½ÃÀ庸°í¼­
»óǰÄÚµå
1424161

¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, ¼¼°è ¹× Áö¿ªº° ½ÃÀå Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® º¸°í¼­ ¹üÀ§ : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Outpatient Central Fulfillment Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, End User, and Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 149 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå ±Ô¸ð´Â 2022³â 3¾ï 932¸¸ ´Þ·¯¿¡¼­ 2030³â 7¾ï 2,579¸¸ ´Þ·¯·Î ±ÞÁõÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022-2030³â ¿¬Æò±Õ 11.3%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ¾à±¹ÀÇ ÀÚµ¿È­ Áõ°¡¿Í Åõ¾à ¿À·ùÀÇ À§ÇèÀº ¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù.

¾à±¹ÀÇ ±â°èÀû ÇÁ·Î¼¼½º¸¦ ÀÚµ¿È­ÇÏ·Á¸é ÀϹÝÀûÀ¸·Î µ¥ÀÌÅͺ£À̽ºÀÇ °í°´ Á¤º¸ ÃßÀû ¹× ¾÷µ¥ÀÌÆ®(º´·Â ¹× ¾à¹° »óÈ£ ÀÛ¿ë À§Çè °¨Áö µî), ÀÛÀº ¹°Ã¼(¿¹ : Á¤Á¦ ¹× ĸ½¶) °è¼ö, ºÐ¸» ¹× ¾×üÀÇ °è·® ¹× Á¶ÇÕ ¹× Áý°è µîÀÇ È°µ¿ÀÌ ÇÊ¿äÇÕ´Ï´Ù. ±× °á°ú ¸¹Àº º´¿ø°ú ¾à±¹¿¡¼­ ÀÚµ¿È­µÈ ¾à±¹À» ¼±È£Çϰí ÀÖ½À´Ï´Ù. ¾à±¹ ÀÚµ¿È­ »ê¾÷Àº ÀǾàǰ¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡, Á¦¾à»ç °£ °æÀï ½ÉÈ­, ±â¼ú ¹ßÀü, Á¤¹ÐÇÑ ·Îº¿ ÀåºñÀÇ °¡¿ë¼º µîÀ¸·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¿À·ù ¾ø´Â ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿Ü·¡ ȯÀÚ Áß¾ÓÁýÁᫎ ÁÖ¹® ó¸® ½ÃÀåÀÌ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦ °ü¸®, ³ôÀº ÀÚº» ¿ä±¸ »çÇ×, ÀÚµ¿È­ ½Ã½ºÅÛ ¿î¿µ°ú °ü·ÃµÈ ¹®Á¦´Â ¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀåÀÇ ¼ºÀåÀ» Á¦ÇÑÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

Åõ¾à ¿À·ùÀÇ À§ÇèÀÌ ¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀåÀ» ÁÖµµ

Åõ¾à ¿À·ù´Â ºÎÀûÀýÇϰí È¿°úÀûÀÌÁö ¾ÊÀº Á¶Á¦·Î ÀÎÇØ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ȯÀÚ¿¡°Ô ÇØ¸¦ ³¢Ä¥ ¼ö ÀÖ´Â ÀϹÝÀûÀÎ Åõ¾à ½Ç¼ö¿¡´Â À߸øµÈ ¾à¹° Á¶Á¦, À߸øµÈ ¾à¹° ¿ë·®, À߸øµÈ ¾à¹° °­µµ µîÀÌ Æ÷ÇԵ˴ϴÙ. ¶ÇÇÑ, ÀÌ·¯ÇÑ ¿À·ù´Â ÀǵµÄ¡ ¾Ê°Ô ´©¶ôµÈ Ç׸ñÀ¸·Î ÀÎÇØ ¹ß»ýÇÒ ¼öµµ ÀÖ½À´Ï´Ù. Åõ¾à ¿À·ù´Â Àü ¼¼°èÀûÀ¸·Î »ç¸Á ¿øÀÎ Áß ¼¼ ¹øÂ°·Î ³ôÀº »ç¸Á ¿øÀÎÀ¸·Î ²ÅÈú Á¤µµ·Î ½É°¢ÇÑ ¹®Á¦ÀÔ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)µµ Åõ¾à ¿À·ù·Î ÀÎÇØ Àü ¼¼°è Àα¸ 100¸¸ ¸í´ç 1¸í²Ã·Î »ç¸ÁÇÏ´Â °ÍÀ¸·Î º¸°í ÀÖ½À´Ï´Ù. ÀÇ·áÀÇ ¾ÈÀüÇÏÁö ¾ÊÀº ÇàÀ§´Â ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ÇÇÇÒ ¼ö ¾ø´Â À§ÇèÀ» ÃÊ·¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ½ÄǰÀǾ౹(FDA)¿¡ µû¸£¸é ¸Å³â 10¸¸ °Ç ÀÌ»óÀÇ ¾à¹° ¿À³²¿ë »ç·Ê°¡ º¸°íµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, 2020³â 6¿ù StatPearls¿¡ °ÔÀçµÈ 'Medication Errors'¶ó´Â Á¦¸ñÀÇ ¿¬±¸¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­´Â ¸Å³â ¾à 7,000-9,000¸íÀÌ Åõ¾à ¿À·ù·Î ÀÎÇØ ¸ñ¼ûÀ» ÀÒ°í ÀÖÀ¸¸ç, 2022³â 9¿ù À¯·´ ÀǾàǰ Á¢±Ù¼º ¿¬ÇÕ(European Alliance for Access to Safe Medicines°¡ 2022³â 9¿ù ¹ßÇ¥ÇÑ ³í¹®¿¡ µû¸£¸é, ¿¬°£ 16¸¸ ¸íÀÌ Åõ¾à ½Ç¼ö·Î »ç¸ÁÇϰí ÀÖ½À´Ï´Ù. ÀÌ ³í¹®Àº ¶ÇÇÑ Åõ¾à ½Ç¼ö°¡ ÀÇ·á ºÐ¾ß¿¡¼­ ¿¹¹æ °¡´ÉÇÑ À§ÇèÀÇ 50%¸¦ Â÷ÁöÇϸç, ¿¬°£ 420¾ï ´Þ·¯ÀÇ ºñ¿ëÀÌ ¹ß»ýÇÑ´Ù°í ¹àÇû½À´Ï´Ù.

»ê¸¸ÇÔÀº ¾à¹° ¿À³²¿ëÀÇ ÁÖ¿ä ¿øÀÎÀÔ´Ï´Ù. »ê¸¸ÇÔÀº ÀÇ·á Àü¹®°¡°¡ ÇÏ·ç Á¾ÀÏ È¯ÀÚ Áø·á, ÄÁ¼³ÅÏÆ®¿ÍÀÇ ´ëÈ­, ȯÀÚ °¡Á·°úÀÇ ´ëÈ­, º¸Çè Àü¹®°¡¿ÍÀÇ ´ëÈ­ µî ¿©·¯ °¡Áö ¾÷¹«¸¦ ¼öÇàÇϱ⠶§¹®¿¡ ¹ß»ýÇÕ´Ï´Ù. ¼­µÑ·¯ ¾÷¹«¸¦ ó¸®ÇÏ·Á´Ù º¸¸é ÆÇ´Ü Âø¿À°¡ ¹ß»ýÇϰí, ÀÌ´Â Åõ¾à ¿À·ù·Î À̾îÁö±âµµ ÇÕ´Ï´Ù.

Åõ¾à ¿À·ùÀÇ ¶Ç ´Ù¸¥ Å« ¿øÀÎÀº ¿Ö°îÀÔ´Ï´Ù. À߸øµÈ ¹®Àå, ¾à¾î, À߸øµÈ ±âÈ£, ºÎÀûÀýÇÑ ¹ø¿ª µîÀ¸·Î ÀÎÇØ ¿Ö°îÀÌ ¹ß»ýÇÕ´Ï´Ù. ¶ÇÇÑ ¾à»ç³ª °£È£»ç´Â ¼ÕÀ¸·Î ¾´ ¾à ó¹æÀüÀ» ÀÌÇØÇϱ⠾î·Á¿ö ȯÀÚ¿¡°Ô ¾àÀ» À߸ø Àü´ÞÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾à¹° ¿À³²¿ëÀÇ °¡´É¼ºÀº ¾à±¹ ¾÷¹« ÀÚµ¿È­¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ¿Ü·¡ ȯÀÚ Áß¾Ó °ü¸® ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ

°í·ÉÈ­ Àα¸ÀÇ Áõ°¡¿Í ½ÅÈï½ÃÀå

°í·ÉÈ­´Â ÇコÄÉ¾î ºÐ¾ß ¹ßÀüÀÇ ÇÙ½ÉÀÔ´Ï´Ù. µû¶ó¼­ °í·ÉÈ­ Àα¸ÀÇ Áõ°¡´Â ¾à±¹¿¡ Áß¿äÇÑ ¼ºÀå ±âȸ°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯¿£ÀÇ 'World Population Prospects 2022' º¸°í¼­¿¡ µû¸£¸é ³ëÀÎ Àα¸´Â 2022³â Àüü Àα¸ÀÇ 10%¿¡¼­ 2050³â 16%±îÁö Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °í·ÉÈ­ Àα¸°¡ ºü¸£°Ô Áõ°¡ÇÔ¿¡ µû¶ó ³ëÀÎ Äɾî¿Í ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä´Â ¾ÕÀ¸·Î ºñ¾àÀûÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àü ¼¼°è Æò±Õ ¼ö¸íÀÇ Áõ°¡·Î ÀÎÇØ ³ëÀÎ Äɾ ´ëÇÑ µðÁöÅÐÈ­ ¹× ÀÚµ¿È­ ½Ã½ºÅÛÀÇ Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. ÀÚµ¿ ÀǾàǰ µð½ºÆæ¼­ÀÇ °³¹ßÀº ¼±Áø±¹¿¡¼­ Å« µµ¿òÀÌ µÇ°í ÀÖÀ¸¸ç, LED µð½ºÇ÷¹ÀÌ, ¸ðÅÍ ÄÁÆ®·Ñ·¯, ¾Ë¶÷ ½Ã½ºÅÛ µîÀÇ Ã·´Ü ±â´ÉÀº ¾à¹° º¹¿ëÀ» »ó±â½ÃŰ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÚµ¿È­µÈ ¾à±¹ ½Ã½ºÅÛÀº ÀǾàǰ°ú Àç°í¸¦ ´õ Àß °ü¸®ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¶ÇÇÑ, ÀÚµ¿È­µÈ ¾à±¹ ½Ã½ºÅÛ µµÀÔÀ¸·Î ¼ºÀÎÀÇ º¹¾à ¼øÀÀµµ°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ¯¼ºÀ¸·Î ÀÎÇØ ÇâÈÄ ¸î ³â µ¿¾È ÀϺ», Àεµ, Çѱ¹, Áß±¹ µî °³¹ßµµ»ó±¹¿¡¼­ ÀÚµ¿È­µÈ ¾à±¹ ½Ã½ºÅÛ µµÀÔÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°³¹ßµµ»ó±¹¿¡¼­´Â ÀÇ·áºñ »ó½Â°ú ÀǾàǰ ¼­ºñ½º Á¢±Ù¼º °³¼±¿¡ ´ëÇÑ ¾Ð·ÂÀ¸·Î ÀÎÇØ ÀǾàǰ °ü¸®°¡ ÇʼöÀûÀÔ´Ï´Ù. ÀǾàǰ¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ôÀ̱â À§ÇØ ½ÅÈï±¹ Á¤ºÎ´Â ´Ù¾çÇÑ Àü·«À» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ³ª¹Ìºñ¾Æ º¸°Ç»çȸºÎ´Â HIV Ä¡·á Á¦°øÀ» °­È­Çϱâ À§ÇØ Ç×·¹Æ®·Î¹ÙÀÌ·¯½º Ä¡·áÀÇ ½ºÄÉÀϾ÷À» ÃËÁøÇϱâ À§ÇØ ´Ù´ÞÀÌ Á¶Á¦ ½Ã½ºÅÛÀ» µµÀÔÇß½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ÇöÀç ³ª¹Ìºñ¾ÆÀÇ ÀÇ·á ½Ã¼³¿¡ ³Î¸® µµÀÔµÇ¾î ±¹°¡ÀÇ HIV Ä¡·á ¸ñÇ¥ ´Þ¼º¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌó·³ °³¹ßµµ»ó±¹ÀÇ ½ÅÈï ½ÃÀåÀº ±â¾÷µé¿¡°Ô »ç¾÷ È®Àå¿¡ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¸¸¼º ÁúȯÀÇ ±ÞÁõ, º´¿øÀÇ ÃֽŠÀÇ·á ±â¼ú äÅ÷ü Áõ°¡, ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¸¹Àº ½ÃÀå ±â¾÷µéÀÌ Áß±¹, Àεµ, ¾Æ¶ø¿¡¹Ì¸®Æ®¿Í °°Àº ½ÅÈï ½ÃÀå¿¡ ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, 2020³â 11¿ù Deenova´Â °ÉÇÁÇù·ÂȸÀÇ(GCC)ÀÇ ¼±µµÀûÀÎ ¾à±¹ ÀÚµ¿È­ ¾÷üÀÎ PharmaTech Medical Equipment¿Í ÆÇ¸Å °è¾àÀ» ü°áÇÏ¿´½À´Ï´Ù. À̸¦ ÅëÇØ DeenovaÀÇ Áßµ¿ Áö¿ª º´¿ø °í°´µéÀº ¿ÏÀü ÀÚµ¿È­µÈ Æ÷Àå ·Îº¿, ¿ÃÀοø ½ºÅ×ÀÌ¼Ç ¹× ÃÖ÷´Ü RFID ¼Ö·ç¼ÇÀ» ÅëÇØ ȯÀÚÀÇ ¾ÈÀü°ú È¿À²¼ºÀ» ´õ¿í Çâ»ó½Ãų ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¾àǰ °ü¸®ÀÇ ¸ðµç ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÏ¿© 15%¿¡¼­ 25%ÀÇ ºñ¿ë Àý°¨ È¿°ú¸¦ ±â´ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ¼¼°è ½ÃÀå"Àº ±â¼ú, Á¦Ç°, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°·Î ¼¼ºÐÈ­µÇ¾î ÀÖ½À´Ï´Ù.

Á¦Ç° À¯Çü¿¡ µû¸¥ ÀλçÀÌÆ®

Á¦Ç° À¯Çü¿¡ µû¶ó ¿Ü·¡ ȯÀÚ Áß¾Ó ÀÌÇà ½ÃÀåÀº ÀÚµ¿ Åõ¾à ½Ã½ºÅÛ, ÀÚµ¿ Æ÷Àå ¹× ¶óº§¸µ ½Ã½ºÅÛ, ÀÚµ¿ Ź»ó Ä«¿îÅÍ, ÀÚµ¿ º¸°ü ¹× °Ë»ö ½Ã½ºÅÛ, ±âŸ À¯ÇüÀ¸·Î ºÐ·ùµÇ¸ç, 2022³â¿¡´Â ÀÚµ¿ Åõ¾à ½Ã½ºÅÛ ºÐ¾ß°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ºÐ¾ß´Â °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÚµ¿ ¾àǰ ºÐ¹è ½Ã½ºÅÛ ¶Ç´Â ÀÚµ¿ ¾àǰ ijºñ´ÖÀº ÁÖ·Î ÀÇ·á ȯ°æ¿¡¼­ ¾àǰÀ» º¸°üÇϰí Á¶Á¦ÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀüÀÚ ÀåÄ¡ÀÔ´Ï´Ù. ¾àǰ Àç°í °ü¸® ¹× º¸¾ÈÀ» À§ÇØ ÀÎÁõµÈ ¾ÏÈ£¿Í »ýü ÀνÄÀ¸·Î º¸È£µÇ´Â ÀÌ ½Ã½ºÅÛÀº ¾àǰÀÇ À¯ÅëÀ» ÃßÀûÇÏ°í °ü¸®ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. BD°¡ Á¦°øÇÏ´Â Pyxis MedStation ½Ã½ºÅÛÀº ¼¼°è¿¡¼­ °¡Àå ¸¹ÀÌ »ç¿ëµÇ´Â ÀÚµ¿ Á¶Á¦ ½Ã½ºÅÛ Áß ÇϳªÀ̸ç, ÇöÀç ¸¹Àº º´¿ø, Ŭ¸®´Ð ¹× ¿ä¾ç ½Ã¼³¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ºÐ»êÇü Åõ¾à °ü¸®¸¦ Áö¿øÇÏ°í ¹ÙÄÚµå ½ºÄµÀ» ÅëÇØ Á¤È®ÇÑ Á¶Á¦¸¦ ½ÇÇöÇÕ´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚ ±â¹Ý ÀλçÀÌÆ®

ÃÖÁ¾»ç¿ëÀÚ¸¦ ±âÁØÀ¸·Î ¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀåÀº º´¿ø ¾à±¹, ¼Ò¸Å ¾à±¹, ¿ìÆí ÁÖ¹® ¾à±¹À¸·Î ±¸ºÐµË´Ï´Ù. º´¿ø ¾à±¹ ºÎ¹®Àº 2022³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, 2022-2030³â ¿Ü·¡È¯ÀÚ Áß¾ÓÁýÁß½Ä Ç®ÇÊ¸ÕÆ® ½ÃÀå¿¡¼­ °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸¹Àº º´¿øÀº Á¤È®¼º, ÀçÇö¼º ¹× ȯÀÚ ¾ÈÀüÀ» º¸ÀåÇϱâ À§ÇØ ¾à±¹ ÀÚµ¿È­ ½Ã½ºÅÛÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ÀϺΠ¿¬±¸¿¡¼­´Â º´¿ø ¾à±¹¿¡¼­ ÃÖ´ë 10%ÀÇ ¼öµ¿ ¿À·ùÀ²ÀÌ °üÂûµÇ¾ú½À´Ï´Ù. 2020³â 3¿ù, Swisslog Healthcare´Â PipelineRx ¹× Savioke¿Í Çù·ÂÇÏ¿© Åð¿ø ½Ã º´¿ø ¿Ü·¡ ¾à±¹ ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇÑ ³ë·ÂÀÎ Meds-to-Beds ÇÁ·Î±×·¥À» ½ÃÀÛÇÏ¿´½À´Ï´Ù. ÇÁ·Î±×·¥À» ½ÃÀÛÇß½À´Ï´Ù. ÀÌ ÇÁ·Î±×·¥¿¡´Â ·Îº¿¿¡ ÀÇÇÑ Ã³¹æ¾à ÀÚµ¿ ¹è¼Û°ú ¾à±¹ ¿ë·® È®´ë¸¦ À§ÇÑ ÄÁ¼³ÆÃÀÌ Æ÷ÇԵ˴ϴÙ. º´¿ø ¾à±¹Àº ȯÀÚ¿¡°Ô ³ôÀº ¼öÁØÀÇ Ä¡·á¸¦ Á¦°øÇØ¾ß ÇÒ Çʿ伺À» ÀνÄÇϰí Àֱ⠶§¹®¿¡ ÀÚµ¿È­ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä´Â ¿¹Ãø ±â°£ µ¿¾È Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¹Ì±¹ ½ÄǰÀǾ౹, Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ, ±¹¸³º¸°Ç¿ø(National Institute for Health and Care Excellence), ±¹¸³º¸°Ç¿ø(National Health Services), À¯·´ÀǾàǰû(European Medicines Agency)Àº ¿Ü·¡È¯ÀÚ Áß¾ÓÃæÁ·µµ ½ÃÀå Á¶»ç º¸°í¼­ ÀÛ¼º ½Ã Âü°íÇÑ °ü·Ã Á¤º¸ Ãâó Áß ÀϺÎÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®

Á¦3Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦4Àå ¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå »óȲ

  • °³¿ä
  • PEST ºÐ¼®
  • »ýÅÂ°è ºÐ¼®
    • ¹ë·ùüÀÎ º¥´õ ¸®½ºÆ®

Á¦5Àå ¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå - ÁÖ¿ä ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¾à±¹ ÀÚµ¿È­
    • Åõ¾à ¹Ì½º ¸®½ºÅ©
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ³ôÀº ÀÚº» ¿ä°Ç°ú ÀÚµ¿È­ ½Ã½ºÅÛ ¿î¿ë¿¡ µû¸¥ ¹®Á¦
  • ½ÃÀå ±âȸ
    • °í·ÉÈ­ Àα¸ Áõ°¡¿Í ½ÅÈï ½ÃÀå
  • ÇâÈÄ µ¿Çâ
    • ±â¾÷ ¼ºÀå Àü·«°ú ÀΰøÁö´É Ȱ¿ë
  • ¿µÇ⠺м®

Á¦6Àå ¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå : ¼¼°è ½ÃÀå ºÐ¼®

  • ¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå ¸ÅÃâ, 2022-2030³â
  • Áö¿ª ºÐ¼® ½ÃÀå ¸ÅÃâ, 2022-2030³â

Á¦7Àå ¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå ºÐ¼® - Á¦Ç° À¯Çüº°

  • ¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå : Á¦Ç° À¯Çüº° ¸ÅÃâ Á¡À¯À²(2022³â¡¤2030³â)
  • ÀÚµ¿ Á¶Á¦ ½Ã½ºÅÛ
  • ÀÚµ¿ Æ÷À塤¶óº§¸µ ½Ã½ºÅÛ
  • ÀÚµ¿ Ź»ó Ä«¿îÅÍ
  • ÀÚµ¿ â°í(ASRS)
  • ±âŸ

Á¦8Àå ¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå ºÐ¼® - ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ Á¡À¯À²(2022³â¡¤2030³â)
  • º´¿ø ¾à±¹
  • ¼Ò¸Å ¾à±¹
  • ÅëÆÇ ¾à±¹

Á¦9Àå ¿Ü·¡ ȯÀÚ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ½ÃÀå °³¿ä
      • ¿µ±¹
      • µ¶ÀÏ
      • ÇÁ¶û½º
      • ÀÌÅ»¸®¾Æ
      • ½ºÆäÀÎ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ APAC
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • Áß³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ Áß³²¹Ì

Á¦10Àå ¿Ü·¡ ȯÀÚ¿ë ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå - ¾÷°è »óȲ

  • ¿Ü·¡ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå ¼ºÀå Àü·«
  • ¹«±âÀû ¼ºÀå Àü·«
  • À¯±âÀû ¼ºÀå Àü·«

Á¦11Àå ±â¾÷ °³¿ä

  • 1.1 Tension Envelope Corp
  • ScriptPro LLC
  • Cardinal Health Inc
  • Omnicell Inc
  • Becton Dickinson and Co
  • RxSafe LLC
  • Custom Health Inc
  • Capsa Solutions LLC
  • Surescripts LLC
  • McKesson Corp

Á¦12Àå ºÎ·Ï

ksm 24.02.23

The outpatient central fulfillment market size is projected to surge from US$ 309.32 million in 2022 to US$ 725.79 million by 2030; the market is estimated to grow at a CAGR of 11.3% during 2022-2030. The rising automation in pharmacies and risk of medication errors propel the outpatient central fulfillment market growth.

Automating the mechanical procedures of any pharmacy process typically entails tracking and updating customer information in databases (e.g., medical history and drug interaction risk detection), counting small objects (e.g., pills and capsules), and measuring and combining powders and fluids for compilation and other such activities. As a result, automated pharmacies are preferred by many hospitals and pharmacies. The pharmacy automation industry is growing due to increased consumer demand for pharmaceutical products, intensified competition among pharmaceutical companies, technological advancements, and precise robotic equipment availability. The increasing demand for error-free medicines is expected to drive the outpatient central fulfillment market. However, stringent regulatory control, high capital requirements, and problems associated with automation system operations limit the growth of the outpatient central fulfillment market.

Risk of Medication Errors Drives the Outpatient Central Fulfillment Market

A medication error can be a result of inappropriate and ineffective medication dispensing. Common medication errors that have the potential to harm patients include dispensing a wrong drug, an incorrect quantity of a drug, and a wrong drug strength. Moreover, these errors may be caused due to omitting items unintentionally. Medication errors are alarming and are considered the third leading cause of death worldwide. The World Health Organization (WHO) also stated that a medication error causes 1 death in 1 million population globally. Unsafe practices in medicine have been causing unavoidable risks in the healthcare sector. According to the US Food and Drug Administration (FDA), over 100,000 reports associated with medication errors are received every year. Further, as per the study titled "Medication Errors" published in StatPearls in June 2020, annually around 7,000-9,000 people in the US lose their lives due to medication errors. An article published by the European Alliance for Access to Safe Medicines in September 2022 states that medication errors result in 160,000 deaths annually. The article also revealed that medication errors account for 50% of preventable risks in the healthcare sector, with a yearly cost of ~US$ 42 billion.

Distractions are the leading cause of medication errors. Distractions occur because healthcare professionals are engaged in multiple tasks throughout the day, including examining the patient, interacting with consultants, speaking to patients' family members, and conversing with insurance professionals. Sometimes a lapse of judgment develops in a hurry to complete their duties, which may lead to a medication error.

Another major cause of medication error is distortion. Poor writing, abbreviations, misunderstood symbols, or improper translation cause distortions. Further, pharmacists and nurses find it difficult to understand the handwritten prescription for medicines, leading to the wrong delivery of medicines to the patients. Thus, the undeniable possibility of medication errors triggers the demand for automation in pharmacy operations, thereby bolstering the growth of the outpatient central fulfillment market.

Market Opportunity

Rising Aging Population and Emerging Markets

The aging population is a key to advancements in the healthcare sector. Thus, the growing aging population is anticipated to serve vital growth opportunity for the pharmacy. According to the United Nations's World Population Prospects 2022 report, the elderly population is projected to increase from 10% of the total population in 2022 to 16% of the total population by 2050. The rapidly growing aging population indicates an exponential rise in demand for elderly care and medicines in the coming years. An upsurge in life expectancy worldwide has also led to the need for more digital and automated systems for adult care. The development of automatic medicine dispensers has served beneficially in developed regions. Advanced features such as an LED display, a motor controller, and an alarm system help people with medication reminders. Automated pharmacy systems would enable them to keep track of their medicine and stocks better. Further, implementing automated pharmacy systems has triggered adult medication adherence. With such features, the adoption of automated pharmacy systems is expected to grow in developing countries such as Japan, India, South Korea, and China in the coming years.

Pharmaceutical management is essential in developing countries owing to rising healthcare costs and pressure to improve access to pharmaceutical services. To ease access to drugs, governments of developing countries are adopting various strategies. For example, the Ministry of Health and Social Services in Namibia has adopted multi-month dispensing to facilitate scale-up of antiretroviral therapy to enhance HIV treatment delivery. This system is now widely implemented in Namibia's health facilities, helping achieve national HIV treatment goals. Thus, emerging markets in developing countries offer lucrative opportunities for the players to expand their business. Most market players focus on emerging markets such as China, India, and the UAE due to the surging prevalence of chronic diseases, rising adoption of the latest medical technologies in hospitals, and increasing awareness about advanced medical technologies.

For instance, in November 2020, Deenova entered into a distribution contract with PharmaTech Medical Equipment, a leading pharmacy automation vendor in the Gulf Cooperation Council (GCC). This has provided Deenova's hospital customers in the Middle East access to fully automated packaging robots, all-in-one stations, and state-of-the-art RFID solutions to further increase patient safety and efficiency. Deenova's solutions simplify all processes related to medication management with expected cost savings ranging from 15% to 25%.

The "Global Outpatient Central Fulfillment Market" is segmented on the basis of technology, offerings, application, end user, and geography.

Product Type-Based Insights

Based on product type, the outpatient central fulfillment market is segmented into automated medication dispensing systems, automated packaging and labeling systems, automated tabletop counters, automated storage and retrieval systems, and other types. The automated medication dispensing systems segment held the largest market share in 2022. The same segment is expected to register the highest CAGR.

An automated medication dispensing system, or automated drug cabinet, is an electronic device primarily used for drug storage and dispensing in healthcare settings. Secured with authenticated passwords and biometrics for drug inventory control and security, these systems aid in tracking and controlling drug distribution. These systems are now widely used in many hospitals, clinics, and nursing homes. The Pyxis MedStation system offered by BD is one of the most used automated dispensing systems in the world. It supports decentralized medication management, and its barcode scanning ensures accurate medication dispensing.

End User-Based Insights

Based on end user, the outpatient central fulfillment market is segmented into hospital pharmacies, retail pharmacies, and mail-order pharmacies. The hospital pharmacies segment held the largest market share in 2022. It is expected to register the highest CAGR in the outpatient central fulfillment market during 2022-2030.

Many hospitals adopt pharmacy automation systems to ensure accuracy, reproducibility, and patient safety. Some studies have observed up to 10% manual error rates in hospital pharmacies. Many studies have proved that using ADM confers more benefits than liability. In March 2020, Swisslog Healthcare partnered with PipelineRx and Savioke to launch the Meds-to-Beds program, an initiative to provide hospital outpatient pharmacy services at discharge. The program includes automatic robotic delivery of prescribed medication and consulting to expand pharmacy capacities. As hospital pharmacies acknowledge the need to provide a high standard of care to patients, the demand for automation equipment is likely to increase significantly during the forecast period.

US Food and Drug Administration, Centers for Disease Control and Prevention, National Institute for Health and Care Excellence, National Health Services, and European Medicines Agency are some of the relevant sources referred while preparing the outpatient central fulfillment market research report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the outpatient central fulfillment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global outpatient central fulfillment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global outpatient central fulfillment market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Outpatient Central Fulfillment Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Outpatient Central Fulfillment Market - Key Market Dynamics

  • 5.1 Outpatient Central Fulfillment Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Automation in Pharmacies
    • 5.2.2 Risk of Medication Errors
  • 5.3 Market Restraints
    • 5.3.1 High Capital Requirements and Problems Associated with Automation System Operations
  • 5.4 Market Opportunities
    • 5.4.1 Rising Aging Population and Emerging Markets
  • 5.5 Future Trends
    • 5.5.1 Growth Strategies by Companies and Use of Artificial Intelligence
  • 5.6 Impact Analysis:

6. Outpatient Central Fulfillment Market - Global Market Analysis

  • 6.1 Outpatient Central Fulfillment Market Revenue (US$ Million), 2022-2030
  • 6.2 Geography Analysis Market Revenue (US$ Million), 2022 - 2030

7. Outpatient Central Fulfillment Market Analysis - by Product Type

  • 7.1 Overview
  • 7.2 Outpatient Central Fulfillment Market Revenue Share, by Product Type 2022 & 2030 (%)
  • 7.3 Automated Medication Dispensing Systems
    • 7.3.1 Overview
    • 7.3.2 Automated Medication Dispensing Systems: Outpatient Central Fulfillment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Automated Packaging and Labelling Systems
    • 7.4.1 Overview
    • 7.4.2 Automated Packaging and Labelling Systems: Outpatient Central Fulfillment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Automated Tabletop Counters
    • 7.5.1 Overview
    • 7.5.2 Automated Tabletop Counters: Outpatient Central Fulfillment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Automated Storage and Retrieval Systems
    • 7.6.1 Overview
    • 7.6.2 Automated Storage and Retrieval Systems: Outpatient Central Fulfillment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Outpatient Central Fulfillment Market - Revenue and Forecast to 2030 (US$ Million)

8. Outpatient Central Fulfillment Market Analysis - by End User

  • 8.1 Overview
  • 8.2 Outpatient Central Fulfillment Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Hospital Pharmacies
    • 8.3.1 Overview
    • 8.3.2 Hospital Pharmacies: Outpatient Central Fulfillment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Retail Pharmacies
    • 8.4.1 Overview
    • 8.4.2 Retail Pharmacies: Outpatient Central Fulfillment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Mail-Order Pharmacies
    • 8.5.1 Overview
    • 8.5.2 Mail-Order Pharmacies: Outpatient Central Fulfillment Market - Revenue and Forecast to 2030 (US$ Million)

9. Outpatient Central Fulfillment Market - Geographical Analysis

  • 9.1 North America Outpatient Central Fulfillment Market, Revenue and Forecast To 2030
    • 9.1.1 Overview
    • 9.1.2 Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
      • 9.1.2.1 North America: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by Product Type
      • 9.1.2.2 North America: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by End User
    • 9.1.3 North America: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by Country
      • 9.1.3.1 US
        • 9.1.3.1.1 Overview
        • 9.1.3.1.2 US: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.1.3.1.3 US: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.1.3.1.4 US: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.1.3.2 Canada
        • 9.1.3.2.1 Overview
        • 9.1.3.2.2 Canada: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.1.3.2.3 Canada: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.1.3.2.4 Canada: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.1.3.3 Mexico
        • 9.1.3.3.1 Overview
        • 9.1.3.3.2 Mexico: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.1.3.3.3 Mexico: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.1.3.3.4 Mexico: Outpatient Central Fulfillment Market Breakdown, by End User
  • 9.2 Europe Outpatient Central Fulfillment Market, Revenue and Forecast To 2030
    • 9.2.1 Market Overview
    • 9.2.2 Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
      • 9.2.2.1 Europe: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by Product Type
      • 9.2.2.2 Europe: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by End User
    • 9.2.3 Europe: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by Country
      • 9.2.3.1 UK
        • 9.2.3.1.1 Overview
        • 9.2.3.1.2 UK: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.2.3.1.3 UK: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.2.3.1.4 UK: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.2.3.2 Germany
        • 9.2.3.2.1 Overview
        • 9.2.3.2.2 Germany: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.2.3.2.3 Germany: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.2.3.2.4 Germany: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.2.3.3 France
        • 9.2.3.3.1 Overview
        • 9.2.3.3.2 France: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.2.3.3.3 France: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.2.3.3.4 France: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.2.3.4 Italy
        • 9.2.3.4.1 Overview
        • 9.2.3.4.2 Italy: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.2.3.4.3 Italy: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.2.3.4.4 Italy: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.2.3.5 Spain
        • 9.2.3.5.1 Overview
        • 9.2.3.5.2 Spain: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.2.3.5.3 Spain: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.2.3.5.4 Spain: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.2.3.6 Rest of Europe
        • 9.2.3.6.1 Overview
        • 9.2.3.6.2 Rest of Europe: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.2.3.6.3 Rest of Europe: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.2.3.6.4 Rest of Europe: Outpatient Central Fulfillment Market Breakdown, by End User
  • 9.3 Asia Pacific Outpatient Central Fulfillment Market, Revenue and Forecast To 2030
    • 9.3.1 Market Overview
    • 9.3.2 Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
      • 9.3.2.1 Asia Pacific: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by Product Type
      • 9.3.2.2 Asia Pacific: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by End User
    • 9.3.3 Asia Pacific: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by Country
      • 9.3.3.1 China
        • 9.3.3.1.1 Overview
        • 9.3.3.1.2 China: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.3.3.1.3 China: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.3.3.1.4 China: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.3.3.2 Japan
        • 9.3.3.2.1 Overview
        • 9.3.3.2.2 Japan: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.3.3.2.3 Japan: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.3.3.2.4 Japan: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.3.3.3 India
        • 9.3.3.3.1 Overview
        • 9.3.3.3.2 India: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.3.3.3.3 India: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.3.3.3.4 India: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.3.3.4 Australia
        • 9.3.3.4.1 Overview
        • 9.3.3.4.2 Australia: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.3.3.4.3 Australia: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.3.3.4.4 Australia: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.3.3.5 South Korea
        • 9.3.3.5.1 Overview
        • 9.3.3.5.2 South Korea: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.3.3.5.3 South Korea: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.3.3.5.4 South Korea: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.3.3.6 Rest of APAC
        • 9.3.3.6.1 Overview
        • 9.3.3.6.2 Rest of APAC: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.3.3.6.3 Rest of APAC: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.3.3.6.4 Rest of APAC: Outpatient Central Fulfillment Market Breakdown, by End User
  • 9.4 Middle East & Africa Outpatient Central Fulfillment Market, Revenue and Forecast To 2030
    • 9.4.1 Market Overview
    • 9.4.2 Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.1 Middle East & Africa: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by Product Type
      • 9.4.2.2 Middle East & Africa: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by End User
    • 9.4.3 Middle East & Africa: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by Country
      • 9.4.3.1 South Africa
        • 9.4.3.1.1 Overview
        • 9.4.3.1.2 South Africa: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.4.3.1.3 South Africa: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.4.3.1.4 South Africa: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.4.3.2 Saudi Arabia
        • 9.4.3.2.1 Overview
        • 9.4.3.2.2 Saudi Arabia: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.4.3.2.3 Saudi Arabia: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.4.3.2.4 Saudi Arabia: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.4.3.3 UAE
        • 9.4.3.3.1 Overview
        • 9.4.3.3.2 UAE: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.4.3.3.3 UAE: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.4.3.3.4 UAE: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.4.3.4 Rest of Middle East & Africa
        • 9.4.3.4.1 Overview
        • 9.4.3.4.2 Rest of Middle East & Africa: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.4.3.4.3 Rest of Middle East & Africa: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.4.3.4.4 Rest of Middle East & Africa: Outpatient Central Fulfillment Market Breakdown, by End User
  • 9.5 South & Central America Outpatient Central Fulfillment Market, Revenue and Forecast To 2030
    • 9.5.1 Market Overview
    • 9.5.2 Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
      • 9.5.2.1 South & Central America: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by Product Type
      • 9.5.2.2 South & Central America: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by End User
    • 9.5.3 South & Central America: Outpatient Central Fulfillment Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.1 Brazil
        • 9.5.3.1.1 Overview
        • 9.5.3.1.2 Brazil: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.5.3.1.3 Brazil: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.5.3.1.4 Brazil: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.5.3.2 Argentina
        • 9.5.3.2.1 Overview
        • 9.5.3.2.2 Argentina: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.5.3.2.3 Argentina: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.5.3.2.4 Argentina: Outpatient Central Fulfillment Market Breakdown, by End User
      • 9.5.3.3 Rest of South & Central America
        • 9.5.3.3.1 Overview
        • 9.5.3.3.2 Rest of South & Central America: Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
        • 9.5.3.3.3 Rest of South & Central America: Outpatient Central Fulfillment Market Breakdown, by Product Type
        • 9.5.3.3.4 Rest of South & Central America: Outpatient Central Fulfillment Market Breakdown, by End User

10. Outpatient Central Fulfillment Market-Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Outpatient Central Fulfillment Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 1.1 Tension Envelope Corp
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 ScriptPro LLC
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Cardinal Health Inc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Omnicell Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Becton Dickinson and Co
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 RxSafe LLC
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Custom Health Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Capsa Solutions LLC
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Surescripts LLC
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 McKesson Corp
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦